பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி Today - Breaking & Trending Today

DOH lifts suspension of AstraZeneca jabs


SunStar
(File)
May 07, 2021
THE Department of Health (DOH) on Friday, May 7, 2021, announced the resumption of vaccinations using the Oxford AstraZeneca vaccine ahead of the expected delivery of two million doses within the month.
The agency said guidelines on the management of adverse events following immunization (AEFI), particularly for the very rare vaccine-induced thrombosis and thrombocytopenia (VITT), have been updated.
VITT is a very rare condition of blood clots associated with low platelet counts that can occur 4 to 28 days after receiving a viral vector vaccine such as AstraZeneca, DOH said in a statement Friday.
Vaccinations using the AstraZeneca vaccine were halted for individuals below 60 years old on April 8 because of recent reports of very rare cases of blood clots. ....

Oxford Astrazeneca , Experts Group On Vaccines , Philippine College Of Hematology , National Adverse Events Following Immunization Committee , Department Of Health , Drug Administration , All Experts Group , Philippine College , Transfusion Medicine , Marites Villamor Ilano , Sunstar Philippines , பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி , துறை ஆஃப் ஆரோக்கியம் , பிலிப்பைன் கல்லூரி , பரிமாற்றம் மருந்து , சன்ஸ்டார் பிலிப்பைன்ஸ் ,

DOH officially resumes use of AstraZeneca COVID-19 vaccine


Published May 7, 2021, 1:42 PM
The Department of Health (DOH) announced on Friday, May 7, the official resumption of using the AstraZeneca coronavirus disease (COVID-19) vaccine in the country.
This file photo taken on November 23, 2020 shows an illustration picture of a syringe and a bottle reading “Covid-19 Vaccine” next to AstraZeneca company and University of Oxford logos. (AFP/ MANILA BULLETIN)
Last April 8, the DOH and the Food and Drug Administration (FDA) temporarily suspended the use of AstraZeneca vaccines for individuals below 60 years old, following reports of rare cases of Vaccine-Induced Thrombosis and Thrombocytopenia (VITT) in some countries.
“After discussions with the DOH All Experts Group and the Philippine College of Hematology and Transfusion Medicine (PCHTM), it was concluded that there are currently no known risk factors for VITT and that the benefits of receiving the vaccine against COVID-19 still outweighs the risk. However, specific ....

Philippine College Of Hematology , National Adverse Events Following Immunization Committee , University Of Oxford , Department Of Health , Drug Administration , Experts Group , Vaccine Induced Thrombosis , Philippine College , Transfusion Medicine , பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , துறை ஆஃப் ஆரோக்கியம் , நிபுணர்கள் குழு , பிலிப்பைன் கல்லூரி , பரிமாற்றம் மருந்து ,

DOH updates guidelines for management of COVID-19 vaccine side effects


By JULIA MARI ORNEDO, GMA News
Published May 7, 2021 2:25pm
The Department of Health (DOH) on Friday said guidelines for the management of COVID-19 vaccine side effects have been updated as it announced the official resumption of AstraZeneca vaccination for people younger than 60.
The DOH approved earlier this month the recommendation to resume the use of the AstraZeneca jab on people under 60 after it was suspended due to concerns on possible blood clotting with low platelet count.
The condition, called vaccine-induced thrombosis and thrombocytopenia (VITT), is a “very rare condition” that can occur four to 28 days after getting a viral vector vaccine like AstraZeneca, the DOH explained. ....

Shirley Domingo , Philippine College Of Hematology , Department Of Health , Philippine Health Insurance Corp , Experts Group , Philippine College , Transfusion Medicine , Philippine Health Insurance , Laging Handa , Philhealth Board , ஷெர்லி டொமிஂகொ , பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி , துறை ஆஃப் ஆரோக்கியம் , பிலிப்பைன் ஆரோக்கியம் காப்பீடு கார்ப் , நிபுணர்கள் குழு , பிலிப்பைன் கல்லூரி , பரிமாற்றம் மருந்து , பிலிப்பைன் ஆரோக்கியம் காப்பீடு ,

Mindanao Examiner Regional Newspaper : DOH resumes use of AstraZeneca vaccines for all age groups


DOH resumes use of AstraZeneca vaccines for all age groups
THE DEPARTMENT of Health (DOH) has reallowed the use of the Oxford AstraZeneca vaccine for all age groups.  
In a statement on Friday, the DOH said based on the recommendation of the Food and Drug Administration (FDA) and the DOH All Experts Group on Vaccines (DOH-AEGV), it was concluded that there are currently “no known risk factors” for vaccine-induced thrombosis and thrombocytopenia (VITT) a very rare condition of blood clots associated with low platelet counts that occur four to 28 days after receiving a viral vector vaccine such as AstraZeneca.
It noted that the benefits of receiving the vaccine “still outweigh the risk”. ....

Oxford Astrazeneca , Raymond Carl Dela Cruz , Technology Vaccine Expert Panel , National Adverse Events Following Immunization Committee , Experts Group On Vaccines , Philippine College Of Hematology , Drug Administration , National Immunization Technical Advisory Group , Technical Advisory Group For Covid , Department Of Science , Health Technology Assessment Council , Experts Group , Philippine College , Transfusion Medicine , Advisory Group , ரேமஂட் கார்ல் டெலா குரூஸ் , தொழில்நுட்பம் தடுப்பூசி நிபுணர் குழு , பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி , துறை ஆஃப் அறிவியல் , ஆரோக்கியம் தொழில்நுட்பம் மதிப்பீடு சபை , நிபுணர்கள் குழு , பிலிப்பைன் கல்லூரி , பரிமாற்றம் மருந்து ,